Aperio Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $436K | Buy |
15,981
+650
| +4% | +$17.7K | ﹤0.01% | 2032 |
|
|
2020
Q3 | $283K | Sell |
15,331
-614
| -4% | -$11.3K | ﹤0.01% | 2091 |
|
|
2020
Q2 | $325K | Sell |
15,945
-5,042
| -24% | -$103K | ﹤0.01% | 1987 |
|
|
2020
Q1 | $306K | Sell |
20,987
-1,760
| -8% | -$25.7K | ﹤0.01% | 1890 |
|
|
2019
Q4 | $323K | Buy |
22,747
+7,822
| +52% | +$111K | ﹤0.01% | 2028 |
|
|
2019
Q3 | $173K | Buy |
14,925
+5,145
| +53% | +$59.6K | ﹤0.01% | 2189 |
|
|
2019
Q2 | $196K | Sell |
9,780
-2,196
| -18% | -$44K | ﹤0.01% | 2184 |
|
|
2019
Q1 | $271K | Buy |
11,976
+2,810
| +31% | +$63.6K | ﹤0.01% | 2050 |
|
|
2018
Q4 | $207K | Buy |
+9,166
| New | +$207K | ﹤0.01% | 2113 |
|